Unravelling the Liver–Heart Disease Connection

A staggering one-third of the global population may harbour metabolic dysfunction associated fatty liver disease (MAFLD). This burgeoning, obesity-related health crisis is projected to escalate, with obesity rates expected to jump from 15% in 2023 to ~25% by 2035. Metadvice stands at the forefront of this challenge, leveraging AI to empower clinicians in managing the complex web of chronic diseases, particularly where metabolic and cardiovascular disorders intersect. In this blog, we draw on new evidence to explore how Metadvice technology can address this growing disease area.